144 related articles for article (PubMed ID: 27233942)
1. Designing piperlongumine-directed anticancer agents by an electrophilicity-based prooxidant strategy: A mechanistic investigation.
Yan WJ; Wang Q; Yuan CH; Wang F; Ji Y; Dai F; Jin XL; Zhou B
Free Radic Biol Med; 2016 Aug; 97():109-123. PubMed ID: 27233942
[TBL] [Abstract][Full Text] [Related]
2. A novel quinazoline-based analog induces G2/M cell cycle arrest and apoptosis in human A549 lung cancer cells via a ROS-dependent mechanism.
Shi H; Li Y; Ren X; Zhang Y; Yang Z; Qi C
Biochem Biophys Res Commun; 2017 Apr; 486(2):314-320. PubMed ID: 28302490
[TBL] [Abstract][Full Text] [Related]
3. Piperlongumine Analogs Promote A549 Cell Apoptosis through Enhancing ROS Generation.
Sun AL; Mu WW; Li YM; Sun YL; Li PX; Liu RM; Yang J; Liu GY
Molecules; 2021 May; 26(11):. PubMed ID: 34071298
[TBL] [Abstract][Full Text] [Related]
4. Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways.
Xiong XX; Liu JM; Qiu XY; Pan F; Yu SB; Chen XQ
Acta Pharmacol Sin; 2015 Mar; 36(3):362-74. PubMed ID: 25619389
[TBL] [Abstract][Full Text] [Related]
5. Promotion of HeLa cells apoptosis by cynaropicrin involving inhibition of thioredoxin reductase and induction of oxidative stress.
Liu T; Zhang J; Han X; Xu J; Wu Y; Fang J
Free Radic Biol Med; 2019 May; 135():216-226. PubMed ID: 30880248
[TBL] [Abstract][Full Text] [Related]
6. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
Kaminska KK; Bertrand HC; Tajima H; Stafford WC; Cheng Q; Chen W; Wells G; Arner ES; Chew EH
Oncotarget; 2016 Jun; 7(26):40233-40251. PubMed ID: 27244886
[TBL] [Abstract][Full Text] [Related]
7. Insights into the importance for designing curcumin-inspired anticancer agents by a prooxidant strategy: The case of diarylpentanoids.
Dai F; Liu GY; Li Y; Yan WJ; Wang Q; Yang J; Lu DL; Ding DJ; Lin D; Zhou B
Free Radic Biol Med; 2015 Aug; 85():127-37. PubMed ID: 25912482
[TBL] [Abstract][Full Text] [Related]
8. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells.
Zhang P; Shi L; Zhang T; Hong L; He W; Cao P; Shen X; Zheng P; Xia Y; Zou P
Cell Oncol (Dordr); 2019 Dec; 42(6):847-860. PubMed ID: 31493144
[TBL] [Abstract][Full Text] [Related]
9. Piperlongumine and immune cytokine TRAIL synergize to promote tumor death.
Li J; Sharkey CC; King MR
Sci Rep; 2015 May; 5():9987. PubMed ID: 25984950
[TBL] [Abstract][Full Text] [Related]
10. EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells.
Shao FY; Wang S; Li HY; Chen WB; Wang GC; Ma DL; Wong NS; Xiao H; Liu QY; Zhou GX; Li YL; Li MM; Wang YF; Liu Z
Oncotarget; 2016 Feb; 7(6):6790-808. PubMed ID: 26758418
[TBL] [Abstract][Full Text] [Related]
11. Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase.
Zhang J; Yao J; Peng S; Li X; Fang J
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):129-138. PubMed ID: 27777067
[TBL] [Abstract][Full Text] [Related]
12. Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation.
Liu JM; Pan F; Li L; Liu QR; Chen Y; Xiong XX; Cheng K; Yu SB; Shi Z; Yu AC; Chen XQ
Biochem Biophys Res Commun; 2013 Jul; 437(1):87-93. PubMed ID: 23796709
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy.
Qian J; Xu Z; Meng C; Liu J; Hsu PL; Li Y; Zhu W; Yang Y; Morris-Natschke SL; Lee KH; Zhang Y; Ling Y
Eur J Med Chem; 2020 Oct; 204():112610. PubMed ID: 32736231
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity induced by inhibition of thioredoxin reductases via multiple signaling pathways: role of cytosolic phospholipase A(2)alpha-dependent and -independent release of arachidonic acid.
Kurosawa T; Nakamura H; Yamaura E; Fujino H; Matsuzawa Y; Kawashima T; Murayama T
J Cell Physiol; 2009 Jun; 219(3):606-16. PubMed ID: 19170071
[TBL] [Abstract][Full Text] [Related]
15. Piperlongumine induces autophagy in biliary cancer cells via reactive oxygen species-activated Erk signaling pathway.
Chen SY; Huang HY; Lin HP; Fang CY
Int J Mol Med; 2019 Nov; 44(5):1687-1696. PubMed ID: 31485612
[TBL] [Abstract][Full Text] [Related]
16. Developing piperlongumine-directed glutathione S-transferase inhibitors by an electrophilicity-based strategy.
Wang HB; Jin XL; Zheng JF; Wang F; Dai F; Zhou B
Eur J Med Chem; 2017 Jan; 126():517-525. PubMed ID: 27914365
[TBL] [Abstract][Full Text] [Related]
17. Piperlongumine downregulates the expression of HER family in breast cancer cells.
Jin HO; Park JA; Kim HA; Chang YH; Hong YJ; Park IC; Lee JK
Biochem Biophys Res Commun; 2017 May; 486(4):1083-1089. PubMed ID: 28377224
[TBL] [Abstract][Full Text] [Related]
18. Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems.
Wang H; Jiang H; Corbet C; de Mey S; Law K; Gevaert T; Feron O; De Ridder M
Cancer Lett; 2019 May; 450():42-52. PubMed ID: 30790679
[TBL] [Abstract][Full Text] [Related]
19. Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer.
Zou P; Xia Y; Ji J; Chen W; Zhang J; Chen X; Rajamanickam V; Chen G; Wang Z; Chen L; Wang Y; Yang S; Liang G
Cancer Lett; 2016 May; 375(1):114-126. PubMed ID: 26963494
[TBL] [Abstract][Full Text] [Related]
20. Increased reactive oxygen species production during reductive stress: The roles of mitochondrial glutathione and thioredoxin reductases.
Korge P; Calmettes G; Weiss JN
Biochim Biophys Acta; 2015; 1847(6-7):514-25. PubMed ID: 25701705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
